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Abstract
OBJECTIVE—To compare the accuracy of surveillance of severe sepsis using electronic health 
record clinical data vs claims and to compare incidence and mortality trends using both methods.
DESIGN—We created an electronic health record–based surveillance definition for severe sepsis 
using clinical indicators of infection (blood culture and antibiotic orders) and concurrent organ 
dysfunction (vasopressors, mechanical ventilation, and/or abnormal laboratory values). We 
reviewed 1,000 randomly selected medical charts to characterize the definition’s accuracy and 
stability over time compared with a claims-based definition requiring infection and organ 
dysfunction codes. We compared incidence and mortality trends from 2003–2012 using both 
methods.
SETTING—Two US academic hospitals.
PATIENTS—Adult inpatients.
RESULTS—The electronic health record–based clinical surveillance definition had stable and 
high sensitivity over time (77% in 2003–2009 vs 80% in 2012, P=.58) whereas the sensitivity of 
claims increased (52% in 2003–2009 vs 67% in 2012, P=.02). Positive predictive values for 
claims and clinical surveillance definitions were comparable (55% vs 53%, P=.65) and stable over 
time. From 2003 to 2012, severe sepsis incidence imputed from claims rose by 72% (95% CI, 
57%–88%) and absolute mortality declined by 5.4% (95% CI, 4.6%–6.7%). In contrast, incidence 
using the clinical surveillance definition increased by 7.7% (95% CI, −1.1% to 17%) and mortality 
declined by 1.7% (95% CI, 1.1%–2.3%).
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CONCLUSIONS—Sepsis surveillance using clinical data is more sensitive and more stable over 
time compared with claims and can be done electronically. This may enable more reliable 
estimates of sepsis burden and trends.
Multiple studies have reported a 2- to 3-fold rise in severe sepsis incidence over the past 
several decades, accompanied by substantial decreases in case fatality rates.1–6 Almost all of 
these estimates are based upon claims data, however, and may therefore be biased by 
increasingly vigilant diagnosis and coding practices.7–9 Indeed, we previously demonstrated 
that the sensitivity of sepsis codes for capturing the most overt form of sepsis, bacteremia 
with concurrent vasopressors or lactic acidosis, has increased significantly over time, and 
that improving documentation of acute organ dysfunction is also likely biasing estimates of 
changing sepsis severity and burden.10,11
Given the questionable reliability of administrative claims to track severe sepsis incidence 
and outcomes, we developed a surveillance definition that uses clinical data instead of 
diagnosis codes and is potentially applicable using electronic health record (EHR) data. Our 
aim was to characterize the accuracy and stability of this definition over time and compare it 
with claims-based definitions, using manual medical chart reviews with the international 
consensus definition as the reference standard. We then estimated and compared changes in 
severe sepsis incidence and mortality rates using the clinical vs claims-based surveillance 
definitions.
METHODS
This was a retrospective cohort study at Massachusetts General Hospital and Brigham and 
Women’s Hospital in Boston, Massachusetts, involving all patients at least 18 years old 
hospitalized from January 1, 2003, through December 31, 2012. The study was approved by 
the Partners Healthcare Institutional Review Board.
Surveillance Definitions Based on EHR Clinical Data
Our surveillance definition for severe sepsis required clinical indicators of suspected 
infection and acute organ dysfunction (Table 1). “Suspected infection” was defined as a 
blood culture order and at least 4 consecutive days of antibiotics (or <4 days if antibiotics 
were continued until at least 1 day prior to death or discharge), with the first day of 
antibiotics required to be a new parenteral agent. Four days was chosen as a minimum 
duration of antibiotic therapy because empirical antibiotics are often stopped after 48–72 
hours when cultures return negative and the patient’s condition is deemed noninfectious. We 
required the antibiotic start date and at least 1 organ dysfunction criterion to occur within ±2 
calendar days of the blood culture order. Organ dysfunction and hypoperfusion were defined 
using criteria and thresholds adapted from the Surviving Sepsis Guidelines, but modified to 
take into account baseline levels of organ dysfunction.12
We excluded lactate levels from our primary definition because the use of serum lactate 
orders has increased dramatically over the past decade.13–16 We performed a sensitivity 
analysis, however, to assess whether and how the inclusion of lactate (with a level 
≥2.0mmol/L) would affect the perceived incidence of severe sepsis over time. We also 
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explored the utility of a parsimonious “simplified surveillance definition” that required only 
evidence of suspected infection and vasopressors, initiation of mechanical ventilation for at 
least 2 days, or an acute rise in creatinine—reflecting the most common forms of organ 
dysfunction associated with sepsis.17–19 We reasoned that if a simpler definition can mirror 
trends detected with a comprehensive definition then it might facilitate future public health 
surveillance efforts across a broader array of hospitals.
Surveillance Definitions Based on Claims Data
We identified patients with claims-based indicators of severe sepsis on hospital discharge 
using the method of Angus et al20 as modified by Iwashyna et al.21 This “implicit” 
definition flags patients with concurrent International Classification of Diseases, Ninth 
Revision, Clinical Modification (ICD-9-CM) codes for infection and organ dysfunction, or 
“explicit” ICD-9-CM codes for severe sepsis or septic shock (995.92, 785.52). Secondarily, 
we examined just the patients with explicit severe sepsis or septic shock codes.
Assessment of Surveillance Definition Accuracy
We compared the accuracy of our clinical and claims-based definitions by reviewing 1,000 
randomly selected medical charts of patients with at least 1 blood culture order while 
hospitalized. We reasoned that blood culture orders were a simple marker that would capture 
the great majority of patients with severe sepsis. We drew 600 medical charts from 
hospitalizations from 2003–2009 and 400 from 2012 in order to be able to assess for 
changes in the sensitivity and positive predictive value (PPV) of our various definitions over 
time while retaining precision of our estimates for the current era. An intensivist (C.R.) 
systematically reviewed each patient’s progress notes, discharge summaries, nursing flow 
sheets, medication records, and microbiology, laboratory, and radiology findings using a 
standardized data collection tool in REDCap22 to determine whether the patient met criteria 
for severe sepsis using the international consensus definition.23 A second intensivist (S.K.) 
independently reviewed 60 randomly selected medical charts (split evenly between those 
initially classified as severe sepsis, septic shock, and non-severe sepsis/septic shock). Each 
reviewer was masked to the other’s findings as well as to patients’ ICD-9-CM codes and 
whether patients were positive with respect to the electronic clinical surveillance definitions. 
Interobserver agreement was assessed using the kappa statistic. After all medical chart 
reviews were complete and surveillance definitions applied, we examined discrepant cases 
to understand reasons for false-positives and false-negatives.
Incidence and Mortality Trends
We applied all surveillance definitions to all patients hospitalized at Massachusetts General 
Hospital and Brigham and Women’s Hospital in 2003–2012 and calculated annual incidence 
and in-hospital mortality rates for patients flagged by each definition.
Data Source
Patients’ demographic characteristics, ICD-9-CM codes, medications, laboratory results, and 
dates of admission, discharge, and death were retrieved from the Partners Research Patient 
Data Registry, a centralized clinical data warehouse that has been in full production since 
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February 2002 and is populated with data extracted from Partners’ home-built EHR 
system.24 We obtained blood culture data from the clinical microbiology laboratories. The 
dates of initiation and discontinuation of mechanical ventilation of all hospitalized patients 
were obtained from the respiratory therapy departments for the Massachusetts General 
Hospital cohort for the entire study period and from Brigham and Women’s Hospital for the 
years 2005–2012. We used ICD-9-CM codes (96.7x) or Current Procedural Terminology 
codes (94002, 94003, or 94004) to identify mechanical ventilation in the Brigham and 
Women’s Hospital population for the years 2003–2004.
Statistical Analyses
Exact 95% binominal CIs were calculated for sensitivity and PPV. Differences in sensitivity 
and PPV in 2012 vs 2003–2009, and between the clinical and claims definitions in 2012, 
were analyzed using the z test for 2 proportions. Ten-year incidence and mortality trends 
were assessed by fitting time series models with linear trends to the observed annual rates. 
The 10-year fitted percent change for incidence was calculated as the ratio between the fitted 
absolute annual change multiplied by 10 and the observed baseline incidence rate in 2003. 
Trends imputed from clinical and claims data were compared through the z score by 
dividing the difference between each slope by the square root of the sum of the variance of 
each fitted trend line. We considered P<.05 to be statistically significant and used 2-sided 
tests. All analyses were performed using SAS, version 9.4 (SAS Institute).
RESULTS
For 2003–2012, there were a total of 901,466 hospitalizations at both hospitals. Of these, 
64,199 (7.1%) flagged the EHR clinical surveillance definition for severe sepsis, 69,075 
(7.7%) met Angus criteria, and 11,096 (1.2%) had explicit severe sepsis or septic shock 
codes.
Accuracy of Surveillance Definitions
Of the 1,000 medical charts reviewed, 220 met criteria for severe sepsis. Agreement 
between the 2 chart reviewers was very good (kappa, 0.8). The characteristics of severe 
sepsis and non-severe sepsis patients are summarized in Table 2. The most common types of 
sepsis-induced organ dysfunction were hypotension (72.3% of cases), acute kidney injury 
(55.9%), and acute respiratory distress syndrome (24.1%). Septic shock was present in 88 
(40%) of the 220 patients with severe sepsis. Lactate levels were measured in an increasing 
fraction of severe sepsis patients over time: 16 (29.6%) of 54 cases in 2003 and 71 (77.2%) 
of 92 cases in 2012 (P< .01). Forty-eight (21.8%) of the 220 patients with severe sepsis died 
in the hospital, compared with 15 (1.9%) of the 780 patients without severe sepsis (P < .01) 
(Table 2).
The accuracy of all surveillance definitions is summarized in Table 3. The sensitivity of the 
primary EHR clinical surveillance definition was stable between 2003–2009 and 2012 
(77.3% vs 80.4%, P = .58), as was the PPV (51.0% vs 52.9%, P= .74). In contrast, the 
sensitivity of Angus codes increased from 51.6% in 2003–2009 to 67.4% in 2012 (P = .02) 
and sensitivity of explicit severe sepsis/septic shock codes increased from 9.4% in 2003–
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2009 to 26.1% in 2012 (P< .01). The PPVs of both claims-based definitions were stable 
across time. Reasons for false-negatives and false-positives for the clinical and Angus 
claims surveillance definitions after review of discrepant cases are detailed in Table 4.
In 2012, the EHR clinical surveillance definition had superior sensitivity compared with the 
Angus definition (80.4% vs 67.4%, P = .04) and the explicit severe sepsis/septic shock 
codes (80.4% vs 26.1%, P < .01). PPV for the clinical surveillance definition (52.9%) was 
similar to the Angus definition (55.4%, P =.69) but less than the PPV for explicit severe 
sepsis/septic shock codes (96.0%, P < .01).
On sensitivity analysis, adding lactate at least 2.0 mmol/L as a criterion increased sensitivity 
and PPV, whereas the simplified definition (suspected infection and vasopressors, 
mechanical ventilation for ≥2 days, or creatinine increase of ≥0.5 mg/dL) had slightly lower 
sensitivity and higher PPV. Both definitions also had stable performance over time.
Of the 48 chart review–confirmed severe sepsis patients who died, the EHR clinical 
surveillance definition flagged 41 (85.4%), the definition with lactates included flagged 42 
(87.5%), and the simplified definition flagged 40 (83.3%). In contrast, the Angus method 
flagged 29 deaths (60.4%) and explicit severe sepsis/septic shock codes flagged 14 (29.2%) 
(P< .01 for all clinical definitions vs either claims definition).
Incidence and Mortality Trends
There were substantial discrepancies between incidence trends derived from surveillance 
using clinical vs claims data (Figure 1). The incidence of severe sepsis using Angus codes 
increased from 519 per 10,000 hospitalizations in 2003 to 867 in 2012 (fitted 10-year 
increase of 72.4%[95% CI, 57.1%–87.6%], P<.01 for linear trend). With explicit severe 
sepsis/septic shock codes, the incidence increased from 21 to 160 per 10,000 
hospitalizations (572% increase, [95% CI, 395%–750%], P<.01). In contrast, there was only 
a modest trend toward more cases using the EHR-based clinical surveillance definition, 
changing from 709 to 757 cases per 10,000 hospitalizations (7.7% increase [95% CI, −1.1% 
to +16.5%], P=.14). When including lactate at least 2.0mmol/L as an additional criterion, 
however, there was a significant increase in incidence, from 712 to 824 cases per 10,000 
hospitalizations (18.6% increase [95% CI, 6.5%–30.6%], P=.02). Annual incidence using 
the simplified definition was stable, changing from 597 to 574 cases per 10,000 
hospitalizations (−4.7% change [95% CI, −15.3% to +5.9%], P=.42).
Annual changes in hospital mortality rates varied similarly (Figure 2). There was a 
substantial mortality decrease using Angus codes from 17.6% in 2003 to 12.6% in 2012 
(fitted absolute 10-year decline of 5.4% [95% CI, 4.1%–6.7%], P< .01), whereas mortality 
using explicit severe sepsis/septic shock codes decreased from 50.0% to 32.2% (17.3% 
decline [95% CI, 15.2%–19.5%], P < .01). In contrast, mortality rates decreased more 
modestly amongst patients meeting the EHR definition, from 15.8% in 2003 to 14.2% in 
2012 (1.7% decline [95% CI, 1.1%–2.3%], P < .01). The mortality rate associated with the 
definition including lactates decreased from 15.8% to 13.6% (2.6% decline [95% CI, 2.0%–
3.2%], P <.01), while mortality associated with the simplified definition was stable: 17.9% 
in 2003 vs 17.5% in 2012 (0.5% decline [95% CI, 0.4%–1.4%], P = .30). All incidence and 
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mortality trends imputed from clinical data were significantly different than trends from 
claims data (P <.01 for all comparisons).
DISCUSSION
We found that a surveillance definition based on EHR clinical data had superior sensitivity 
for identifying hospitalizations with severe sepsis compared with claims-based methods. The 
PPV of this definition was similar to the widely used modified Angus method but lower than 
explicit severe sepsis/septic shock codes. However, the clinical surveillance definition 
demonstrated stable performance over time, whereas the sensitivity of both claims methods 
increased, particularly the explicit severe sepsis/septic shock codes. On applying the 
definition to all hospitalized patients over 10 years, we found a much more modest increase 
in severe sepsis incidence and decline in hospital mortality compared with claims-based 
estimates.
The increasing sensitivity of claims over the past decade suggests that clinicians and coders 
are becoming better at appropriately recognizing and coding for sepsis and/or organ 
dysfunction over time. This is likely due to increasing awareness of sepsis, financial 
incentives to code for higher patient complexity, and the introduction of new diagnosis 
codes.7–11 The larger decrease in mortality rates of patients with sepsis codes compared with 
that of patients fulfilling our clinical surveillance definition suggests that sepsis codes are 
being assigned to less ill patients over time. The stable PPV for these codes, however, 
suggests that they are nonetheless appropriate. Our findings do, however, underscore the 
need for more credible ways to measure sepsis rates over time, which is particularly 
important in light of the profusion of sepsis prevention initiatives and new governmental 
regulations compelling hospitals to adopt sepsis protocols and report adherence to quality 
measures.9 The EHR-based clinical surveillance method had stable performance over time, 
suggesting that it may give more reliable estimates of changes in disease incidence and 
mortality than claims.
Our analysis of the true severe sepsis cases missed by the EHR clinical surveillance 
definition revealed that most were either sepsis manifested solely by transient hypotension 
(a less severely ill group whose importance of capturing for surveillance can be debated) or 
due to failure of the antibiotic criteria to capture septic patients. Reassuringly, only 2 cases 
were missed because organ dysfunction occurred outside the ±2 day infection window 
period, suggesting that this is a reasonable timeframe for surveillance. Unsurprisingly, most 
false-positive cases with the EHR definition were due to the lack of a causal association 
attributed by the reviewer between infection and organ dysfunction. However, for purposes 
of standardizing surveillance, removing this potentially subjective assessment is likely to be 
beneficial.
Our study supports the feasibility of large-scale, automated, objective sepsis surveillance 
using EHR clinical data. At present there are relatively few large healthcare networks with 
complete electronic data spanning many years; however, the increasing adoption of EHR 
systems is making automatable public surveillance increasingly feasible. We note that 
surveillance using a parsimonious set of organ dysfunction criteria (vasopressors, 
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mechanical ventilation, and rise in creatinine) had slightly lower sensitivity, and slightly 
higher PPV, compared with our full surveillance definition, with similar observed trends in 
incidence over time. This type of definition, with its relatively simple criteria, may facilitate 
surveillance across a broader array of facilities. In addition, the EHR-based clinical 
surveillance definitions captured more of the severe sepsis deaths compared with claims. 
Resources spent on surveillance should ideally capture events associated with the greatest 
risk of adverse outcomes in order to help target and monitor prevention efforts most 
efficiently.
When lactate was added as a surveillance criterion, there was a significant increase in sepsis 
incidence, though still less than that imputed with claims. This is likely due to the increasing 
use of lactate testing over time and extension to patients without evidence of other organ 
dysfunction.16 This may reflect the impact of the Surviving Sepsis Campaign guidelines and 
numerous publications suggesting that measuring lactate levels is beneficial.12,25–28 Our 
findings suggest that although lactate measurement may be important for the clinical care of 
individual patients, it is less suited to helping estimate changes in population-level sepsis 
burden over time because of significant increases in testing rates.
Our study has several important limitations. First, we included data from only 2 academic 
hospitals, which may limit the generalizability of our findings. However, the incidence, 
clinical characteristics, and mortality rate of our severe sepsis cohort resembles that reported 
in other studies,29–31 as do the performance characteristics of the claims methods we 
examined and their associated incidence and mortality trends.21,32,33 Second, a single 
reviewer classified cases as severe sepsis using international consensus definitions. Cases 
were reviewed using structured forms, however, and there was excellent agreement with a 
second masked reviewer on a random subset of medical charts. Third, we limited our 
surveillance to patients with blood culture orders. It is unlikely, however, that many patients 
with severe sepsis did not have blood cultures ordered since the threshold for ordering blood 
cultures is very low in severely ill patients.29,34 Fourth, several components of our 
surveillance definition rely on therapeutic maneuvers that may have varying thresholds 
between clinicians and institutions, such as initiation of antibiotics, vasopressors, and 
mechanical ventilation. However, claims-based methods also rely on capturing treatment 
modalities including mechanical ventilation.31 Fifth, the modified Angus definition includes 
codes for neurologic dysfunction, but we did not include this as one of the clinical criteria. 
We felt this was justified because altered mental status was not included in the most recent 
Surviving Sepsis Guidelines’ definition of severe sepsis.12 Sixth, our data do not directly 
speak to the performance of ICD-10 codes, which are now being implemented in the United 
States. However, having a surveillance measure that is stable over time will only become 
more important as clinicians become more comfortable and proficient with the new coding 
scheme. Moreover, the clinical forces leading clinicians to be increasingly more vigilant 
about detecting and treating sepsis will continue independently of the introduction of 
ICD-10. Notably, a recent systematic review of the validity of sepsis claims found that the 
sensitivity of ICD-10 codes in other countries ranged from 5.9% to 52.5%—well below the 
sensitivity of our EHR definitions.35 Lastly, examination of trends using clinical data cannot 
be viewed as definitive since both sensitivity and PPV of the surveillance definitions were 
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imperfect. Nonetheless, the stable sensitivity and PPV of the clinical surveillance definitions 
across time support their use as proxies for severe sepsis over the entire decade.
In conclusion, a surveillance definition for severe sepsis based upon routinely collected EHR 
clinical data was more sensitive and resistant to changes in performance over time compared 
with claims-based methods. When we applied the surveillance definition to 10 years of data 
from 2 large hospitals, we found that severe sepsis incidence has been rising more modestly 
and mortality declining less rapidly compared with claims-based estimates. The use of EHR 
clinical data warrants further exploration for routine public health surveillance.
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Severe sepsis incidence trends using surveillance definitions based on electronic health 
record (EHR) clinical data versus claims data, 2003–2012. Percentages next to each method 
refer to fitted 10-year change relative to 2003, with associated 95% confidence limits.
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Severe sepsis mortality trends using surveillance definitions based on electronic health 
record (EHR) clinical data versus claims data, 2003–2012. Percentages next to each method 
refer to fitted absolute 10-year change, with associated 95% confidence limits.
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TABLE 1
Comparison of the International Consensus Definition of Severe Sepsis and Surveillance Definition Based on 
Electronic Health Record (EHR) Clinical Data
Severe Sepsis Consensus Definitiona EHR Clinical Surveillance Definition
Sepsis 1 Suspected or documented infection +
2 ≥2 systemic inflammatory response syndrome 
criteria:
• Temperature >38.3°C or <36° C
• Heart rate >90 beats/min
• Respiratory rate >20 breaths/min or 
mechanical ventilation or pCO2 
<32mm Hg
• White blood cell count >12,000 or 
<4,000 μL, or >10% bands +
1 Blood culture order +
2 New intravenous antibiotic followed by any 
systemic antibioticb every day for total ≥4 
antibiotic days (or until 1 day prior to 
discharge or death) +
Organ Dysfunction 3 Any of the following thought to be due to 
sepsis:
• Hypotension (systolic blood pressure 
<90mm Hg or drop by >40mm Hg, or 
mean arterial pressure <65mm Hg)
• Serum lactate ≥2.0 mmol/L
• Acute lung injury with PaO2/FiO2 
<250 in the absence of pneumonia as 
infection source, or <200 in the 
presence of pneumonia as infection 
source
• Urine output <0.5 mL/kg/hr for more 
than 2 hours despite adequate fluid 
resuscitation
• Creatinine increase by ≥0.5 mg/dL 
from baseline
• Total bilirubin ≥2 mg/dL
• Platelet count <100,0000 μL
• Coagulopathy (INR >1.5
3 ≥ 1 organ dysfunction marker:
• Any vasopressorc
• Initiation of mechanical 
ventilation, continued for ≥2 
continuous calendar days (or 1 day 
if death occurs that day)
• Creatinine increase by ≥0.5 mg/dL 
from baselined (excluding patients 
with end-stage renal diseasee)
• Total bilirubin ≥2.0 mg/dL and 
increase by 100% from baselined
• Platelet count <100 μL and ≥50% 
decline from baselined
• INR >1.5 and ≥0.5 increase from 
baselined (excluding patients on 
warfarinf)
• (Serum Lactate ≥2.0 mmol/L)g
EHR Clinical Surveillance 
Definition fulfilled if criteria 2 
and 3 occur within ±2 days of 
blood culture order
NOTE. INR, international normalized ratio.
a
Adapted from the 1991 American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee, 2001 Society 
of Critical Care Medicine/ European Society of Intensive Care Medicine/American College of Chest Physicians/ American Thoracic Society/ 
Surgical Infection Society International Sepsis Definitions Conference, and 2012 Surviving Sepsis Campaign Guidelines.
b
New intravenous antibiotic defined by washout period of 2 days. Any subsequent oral antibiotic also requires washout period of 2 days.
c
Vasopressor=norepinephrine, dopamine, vasopressin, epinephrine, phenylephrine.
d
Baseline values are defined as lowest for creatinine, bilirubin, and INR from day −30 of hospitalization admission to day of discharge, or the 
highest for platelets from day −30 of admission to day of discharge.
e
End-stage renal disease defined by International Classification of Diseases, Ninth Revision, Clinical Modification code of 585.6.
f
Any order for warfarin from day −30 of admission to day of hospital discharge.
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g
Serum lactate was not included in the primary surveillance definition, but was included in a secondary definition.













Rhee et al. Page 15
TABLE 2
Characteristics of Patients With Severe Sepsis Determined by Medical Record Review
Variable Severe Sepsis (n= 220) No Severe Sepsis (n= 780) P value
Age, median (IQR), y 65.0 (54.5–76.0) 59.5 (44.5–72.0) <.01
Male sex 121 (55.0) 396 (50.8) .27
Nonwhite race 51 (23.2) 219 (28.1) .15
Primary hospital service
 Medical 180 (81.8) 528 (67.7) <.01
 Surgical 32 (14.6) 165 (21.2) .03
 Other 8 (3.6) 87 (11.2) <.01
Comorbidities (Elixhauser)
 Cancer 48 (21.8) 179 (22.9) .72
 Diabetes mellitus 34 (15.5) 167 (21.4) .05
 Heart failure 54 (24.5) 100 (12.8) <.01
 Liver disease 13 (5.9) 35 (4.5) .39
 Lung disease 28 (12.7) 121 (15.5) .30
 Renal disease 35 (15.9) 89 (11.4) .08
Primary source of infection
 Pulmonary 87 (39.5) 170 (21.8) <.01
 Urinary 32 (14.5) 68 (8.7) .01
 Skin and soft tissue 10 (4.5) 74 (9.5) .02
 Gastrointestinal/intra-abdominal 44 (20.0) 74 (9.5) <.01
 Central nervous system 4 (1.8) 9 (1.2) .44
 Other 43 (19.6) 93 (11.9) <.01
 No infection 0 (0) 292 (37.4) NA
Positive blood culture 58 (26.4) 41 (5.3) <.01
Hospital-onset severe sepsis 62 (28.2) NA –
Organ dysfunction attributable to sepsis
 Hypotension 159 (72.3) NA –
 Acute kidney injury/oliguria 123 (55.9) NA –
 Lactate ≥2.0 mmol/L 74 (33.6) NA –
 Acute respiratory distress syndrome 53 (24.1) NA –
 Thrombocytopenia 37 (16.8) NA –
 Coagulopathy 33 (15.0) NA –
 Hepatic injury 28 (12.7) NA –
Outcomes
 Hospital length of stay, median (IQR), d 11 (6–20.5) 6 (4–11) <.01
 Required intensive care unit 124 (56.4) 152 (19.5) <.01
 Death in hospital 48 (21.8) 15 (1.9) <.01
NOTE. Data are no. (%) of patients, unless otherwise specified. IQR, interquartile range.
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TABLE 4
Reasons for False-Negatives and False-Positives for Surveillance Definitions Relative to Severe Sepsis 





N=47a (of 220 chart review-confirmed severe sepsis cases) N= 162a (of 334 EHR definition-positive cases)
• Sepsis-induced hypotension without vasopressors or 
other organ dysfunction (n =22)
• Sepsis episode not captured by EHR antibiotic criteria 
(n =18):
– Antibiotics not given on each day for ≥4 day 
course (n= 6)
– Did not meet required ≥4 day antibiotic 
course duration (n =4)
– Parenteral antibiotic given was not a “new” 
agent (n =4)
– Antibiotic administration not captured by 
EHR (n= 2)
– Only given oral antibiotics (n =1)
– Not given antibiotics due to being made 
comfort care (n =1)
• Lactate ≥2.0 mmol as sole manifestation of organ 
dysfunction (n =4)
• EHR rule for baseline organ dysfunction not 
consistent with reviewer’s assessment (n =4)
• Sepsis-induced organ dysfunction that occurred 
outside ±2 day infection window (n =2)
• No evidence of infection despite blood 
culture order and course of antibiotics (n 
=33)
• Infection present, but organ dysfunction 
flagged by definition deemed not to be 
attributable to sepsis (n =129):
– Creatinine rise (n= 46)
– Thrombocytopenia (n =44)
– Vasopressors (n =25)
– Mechanical ventilation (n= 24)
– Bilirubin rise (n =20)




N=91a (of 220 chart review-confirmed severe sepsis cases) N= 111a (of 240 Angus claims-positive cases)
• Not coded for infection (n =33)
• Coded for infection but not coded for sepsis-induced 
organ dysfunction (n = 56):
• Hypotension or shock (n= 42)
– Acute kidney failure (n =24)
– Thrombocytopenia (n =3)
– Respiratory failure (n =2)
– Liver dysfunction (n= 2)
• Lactate as sole manifestation of sepsis-induced organ 
dysfunction so not captured by coding scheme (n =2)
• Coded for organ dysfunction that was 
deemed not to be attributable to sepsis (n 
=111):
– Acute kidney failure (n =53)
– Ventilator use (n =22)
– Hypotension or shock (n =20)
– Thrombocytopenia (n =17)
– Delirium/encephalopathy (n =12)
– Liver dysfunction (n =3)
– Coagulopathy (n =1)
NOTE. EHR, electronic health record; INR, international normalized ratio.
a
Numbers in each cell do not necessarily add up to total N because several cases had multiple reasons for false-negative or false-positive status.
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